Fresenius - the health care group
The Fresenius Group consists of the following four business segments that are responsible for their own business operations worldwide: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed.
Latest news
Ulf Mark Schneider, CEO of Fresenius, commented: “2011 was another highly successful year for Fresenius. Our group net income increased by 18% in constant currency after 23% growth in 2010. Based on these strong results we will propose the 19th consecutive dividend increase to our shareholders...”
>>>Fresenius Medical Care AG & Co. KGaA today announced its results for the fourth quarter and full year of 2011.
>>>Fresenius will continue the legal dispute concerning the payment of legal fees at the German Federal Court of Justice. The court granted Fresenius’ complaint against the Frankfurt am Main Higher Regional Court’s decision issued on February 15, 2011.
>>>Fresenius Medical Care successfully placed three tranches of U.S. dollar and euro-denominated senior unsecured notes (together the “senior notes”). Proceeds amounting to approximately $1.82 billion are intended to be used for acquisitions, including the acquisition of Liberty Dialysis Holdings, Inc., to refinance indebtedness and for general corporate purposes.
>>>Fresenius Medical Care today announced its intention to sell U.S. dollar and euro-denominated senior unsecured notes (together the “senior notes”) of $1.2 billion and €250 million. The tranches will have a maturity between 7.5 and 10 years.
>>>